The Independent Valuation is out.
You have to go to another site to download it. Starts with Share ends with scene.
It should be noted that this is a sum-of-parts valuation and not a valuation of the Company per se. A Company valuation would consider life to perpetuity, usuallyachieved through the inclusion of a terminal value, and additional expenses, such as continuing research and development to ensure sustainability, with the net effect that a Company valuation would be higher than presented here. Although such an analysis requires access to additional information concerning the Company and its prospects, a rough analysis suggests a valuation range from $410 million ($1.80 per share) to $515
million ($2.26 per share).
AAH
arana therapeutics limited
